Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system
Article in The European Journal of Health Economics (April 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies
Article in Oncology and Therapy (February 2024)
Productivity losses from short-term work absence due to neoplasms in Poland
Article in Scientific Reports (February 2024)